Letter: C1 inactivation from cancer cells

PASSHIV-1 treatment of patients with HIV-1 infection. A preliminary report of a phase I trial of hyperimmune porcine immunoglobulin to HIV-1.

AIDS (London, England)·1992

Protective humoral immune responses to the human immunodeficiency virus induced in immunized pigs: a possible source of therapeutic immunoglobulin preparations.

Hybridoma·1991

A rapid screening test for HIV-1 antibodies: application to biological studies on human tissue.

Life sciences·1991

The quick western blot, a novel transportable 50-minute HIV-1 antibody test. Application in organ procurement for transplantation.

Transplantation·1989

Expression of c-myc and c-Ha-ras oncogenes in human lymphoblastoid cells (Namalva).

Cellular and molecular biology·1989

Antiproliferative assay of human leucocyte interferon.

The Tohoku journal of experimental medicine·1987

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

FAP as a Clinical Biomarker: FAP+ CAFs Orchestrate an Immunosuppressive Stem Cell Niche via the COL1A1/2-CD44 Axis in Colon Cancer.

Stem cells international·2026

Saccharomyces cerevisiae in cancer research: modeling tumor biology and enabling drug discovery.

Microbial cell (Graz, Austria)·2026

Deep visual multi-omics profiling links morphology and molecular programs in clear cell renal cell carcinoma.

EMBO molecular medicine·2026

Deubiquitinase inhibition exposes a subtype-specific vulnerability in SCLC-P.

Trends in cancer·2026

Lysosomal metabolism in pancreatic cancer and its crosstalk with host physiology.

Genes & development·2026

[Pathophysiological and biological mechanisms in frailty].

Ugeskrift for laeger·2026

Related Experiment Videos

Letter: C1 inactivation from cancer cells

Related Concept Videos

PASSHIV-1 treatment of patients with HIV-1 infection. A preliminary report of a phase I trial of hyperimmune porcine immunoglobulin to HIV-1.

Protective humoral immune responses to the human immunodeficiency virus induced in immunized pigs: a possible source of therapeutic immunoglobulin preparations.

A rapid screening test for HIV-1 antibodies: application to biological studies on human tissue.

The quick western blot, a novel transportable 50-minute HIV-1 antibody test. Application in organ procurement for transplantation.

Expression of c-myc and c-Ha-ras oncogenes in human lymphoblastoid cells (Namalva).

Antiproliferative assay of human leucocyte interferon.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

FAP as a Clinical Biomarker: FAP+ CAFs Orchestrate an Immunosuppressive Stem Cell Niche via the COL1A1/2-CD44 Axis in Colon Cancer.

Saccharomyces cerevisiae in cancer research: modeling tumor biology and enabling drug discovery.

Deep visual multi-omics profiling links morphology and molecular programs in clear cell renal cell carcinoma.

Deubiquitinase inhibition exposes a subtype-specific vulnerability in SCLC-P.

Lysosomal metabolism in pancreatic cancer and its crosstalk with host physiology.

[Pathophysiological and biological mechanisms in frailty].

Related Experiment Videos

Letter: C1 inactivation from cancer cells

Related Concept Videos

Related Articles